It can be achieved through dietary modulation, recombinant methioninase, or targeting pathways such as SAM synthesis, and has demonstrated significant efficacy with manageable safety in both preclinical and clinical studies, thus holding broad prospects in cancer therapy
So, my question to you, Seth, is what do you see as the probability around both of those scenarios
Actual timepoints come directly from published trial data at specific weeks: 4, 8, 12, 16, 20, 24, 32, 40, and 48
Walking helps you take your first steps (sorry, had to) toward an active, movement-focused lifestyle
2) suggests that BPC 157 administration prevents the chain of events after spinal cord injury that is mediated by the loss of local segmental inhibition and/or by an increased sensory afferent drive that results in the exacerbation of -motoneuron activity [66]